|
FIP1L1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.74960062998753E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.49599998634199E-09 |
| Normal-vs-Stage2 |
1.39470000004582E-06 |
| Normal-vs-Stage3 |
2.34819941269393E-11 |
| Normal-vs-Stage4 |
4.47459846952825E-11 |
| Stage1-vs-Stage2 |
2.861000E-01 |
| Stage1-vs-Stage3 |
2.242100E-02 |
| Stage1-vs-Stage4 |
9.776100E-03 |
| Stage2-vs-Stage3 |
5.780400E-01 |
| Stage2-vs-Stage4 |
4.037600E-01 |
| Stage3-vs-Stage4 |
6.905600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.867395458381E-11 |
| Normal-vs-AfricanAmerican |
1.880550E-03 |
| Normal-vs-Asian |
1.170380E-04 |
| Caucasian-vs-AfricanAmerican |
3.292400E-01 |
| Caucasian-vs-Asian |
2.117800E-01 |
| AfricanAmerican-vs-Asian |
9.658600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.41600131199039E-11 |
| Normal-vs-Female |
2.39460007378511E-10 |
| Male-vs-Female |
2.175200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.33759999965122E-07 |
| Normal-vs-Age(41-60Yrs) |
3.53440055000931E-10 |
| Normal-vs-Age(61-80Yrs) |
2.56272780774225E-12 |
| Normal-vs-Age(81-100Yrs) |
7.74669999999977E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.450600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.281270E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.628440E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.855900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.955000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.335000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.248190E-02 |
| Classical-VS-Follicular |
1.039430E-01 |
| Classical-VS-Other |
5.622600E-01 |
| Classical-VS-Normal |
1.18720000052974E-07 |
| Tall-VS-Follicular |
2.192200E-01 |
| Tall-VS-Other |
4.837400E-01 |
| Tall-VS-Normal |
1.6211000319899E-09 |
| Follicular-VS-Other |
9.704800E-01 |
| Follicular-VS-Normal |
2.50880000107756E-08 |
| Other-VS-Normal |
6.521000E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.60710000862707E-10 |
| Normal-vs-N1 |
3.61599999942896E-08 |
| N0-vs-N1 |
3.688400E-01 |
|
|
